These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18801825)

  • 1. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.
    Montejo AL; Prieto N; Terleira A; Matias J; Alonso S; Paniagua G; Naval S; Parra DG; Gabriel C; Mocaër E; Portolés A
    J Psychopharmacol; 2010 Jan; 24(1):111-20. PubMed ID: 18801825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
    Montejo AL; Deakin JF; Gaillard R; Harmer C; Meyniel F; Jabourian A; Gabriel C; Gruget C; Klinge C; MacFayden C; Milligan H; Mullings E; Goodwin G
    J Psychopharmacol; 2015 Oct; 29(10):1119-28. PubMed ID: 26268533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.
    Kennedy SH; Rizvi S; Fulton K; Rasmussen J
    J Clin Psychopharmacol; 2008 Jun; 28(3):329-33. PubMed ID: 18480691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.
    Montgomery SA; Kennedy SH; Burrows GD; Lejoyeux M; Hindmarch I
    Int Clin Psychopharmacol; 2004 Sep; 19(5):271-80. PubMed ID: 15289700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders.
    Montejo AL; Rico-Villademoros F
    J Sex Marital Ther; 2008; 34(3):227-39. PubMed ID: 18398761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions].
    Montejo AL; García M; Espada M; Rico-Villademoros F; Llorca G; Izquierdo JA
    Actas Esp Psiquiatr; 2000; 28(3):141-50. PubMed ID: 11000695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of agomelatine on sexual function in depressed patients and healthy volunteers.
    Montejo A; Majadas S; Rizvi SJ; Kennedy SH
    Hum Psychopharmacol; 2011 Dec; 26(8):537-42. PubMed ID: 22102540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
    Jacobsen P; Zhong W; Nomikos G; Clayton A
    J Sex Med; 2019 Oct; 16(10):1638-1649. PubMed ID: 31405765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
    Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.
    Lôo H; Hale A; D'haenen H
    Int Clin Psychopharmacol; 2002 Sep; 17(5):239-47. PubMed ID: 12177586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
    Stein DJ; Ahokas AA; de Bodinat C
    J Clin Psychopharmacol; 2008 Oct; 28(5):561-6. PubMed ID: 18794654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
    Demyttenaere K; Corruble E; Hale A; Quera-Salva MA; Picarel-Blanchot F; Kasper S
    CNS Spectr; 2013 Jun; 18(3):163-70. PubMed ID: 23472671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.
    Stein DJ; Ahokas A; Albarran C; Olivier V; Allgulander C
    J Clin Psychiatry; 2012 Jul; 73(7):1002-8. PubMed ID: 22901350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of agomelatine in depression: the evidence.
    den Boer JA; Bosker FJ; Meesters Y
    Int Clin Psychopharmacol; 2006 Feb; 21 Suppl 1():S21-4. PubMed ID: 16436936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
    Goodwin GM; Emsley R; Rembry S; Rouillon F;
    J Clin Psychiatry; 2009 Aug; 70(8):1128-37. PubMed ID: 19689920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on agomelatine.
    Green B
    Curr Med Res Opin; 2011 Apr; 27(4):745-9. PubMed ID: 21271795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine: an antidepressant without deterioration of sexual response.
    Sapetti A
    J Sex Marital Ther; 2012; 38(2):190-7. PubMed ID: 22390531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.
    Liang Z; Jia Y; Zhao L; Zhu R; He X; Tong B; Yang F; Hao L; Cui P; Yuan J
    Aging (Albany NY); 2021 Oct; 13(19):22934-22946. PubMed ID: 34610580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion.
    Abler B; Seeringer A; Hartmann A; Grön G; Metzger C; Walter M; Stingl J
    Neuropsychopharmacology; 2011 Aug; 36(9):1837-47. PubMed ID: 21544071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.